🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Moxifloxacin is routinely used as a probe to confirm assay sensitivity in t...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2011-07
Trial ID
NCT01642485
The purpose of this clinical trial is to learn if the study medicine (calle...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2022-10-17
Trial ID
NCT05580003
Treatments Being Tested
The purpose is to evaluate the effect of single therapeutic (400 mg) and su...
Status
Completed
Location
Covance Clinical Research Unit Ltd.
Start Date
2018-04-09
Trial ID
NCT03489005
Treatments Being Tested
The purpose of this study is to investigate the effect of PH-797804 followi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-04
Trial ID
NCT01862887
Treatments Being Tested
The objective of this study was to evaluate the effects of cebranopadol (GR...
Status
Completed
Location
US001 Contract research organization
Start Date
2013-07-10
Trial ID
NCT03958123
The aim of such a study is to evaluate the impact of a therapeutic dose of ...
Status
Completed
Location
SGS aster s.a.s
Start Date
2010-02
Trial ID
NCT01103830
The purpose of this study is to evaluate the effect of an 800-mg single dos...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01291563
Treatments Being Tested
This study is comprised of two parts. The purpose of the first part of this...
Status
Completed
Location
Altasciences Clinical Kansas, Inc
Start Date
2022-06-22
Trial ID
NCT05478278
Treatments Being Tested
The purpose of this study is to describe the pharmacokinetics of a new oral...
Status
Completed
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01073891
Treatments Being Tested
The main purpose of this study is to assess the effect of a single suprathe...
Status
Completed
Location
Celerion
Start Date
2017-05-12
Trial ID
NCT03155893
Treatments Being Tested